Condition
Takayasu Arteritis clinical trials and research
As of November 12, 2026, Find a Trial lists 10 Takayasu Arteritis clinical trials that are recruiting, at sites in 8 countries (most in United Kingdom (2), China (2), Turkey (Türkiye) (2)). By phase: Phase 4 (3), Phase 2 (1). The most active sponsors are University of Edinburgh (2), Shanghai Zhongshan Hospital (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 10Clinical trials
- 8Countries
Newest Takayasu Arteritis clinical trials
All recruiting trials (10)
-
Stopping biologic therapy in Takayasu arteritis patients in long-term remission
This study will try stopping biologic medicines (TNF inhibitors or tocilizumab) in people with Takayasu arteritis who have been in clinical and imaging remission for at least three years to see if remission lasts for 12 months.
-
Understanding patient and physician experiences and attitudes toward care in Takayasu arteritis.
This project asks adults with Takayasu arteritis and the doctors who treat them to complete online questionnaires to see what their experiences and care priorities are.
-
Comparing physical and psychosocial health in people with Takayasu arteritis, Behçet's disease, and healthy adults
This will test whether adults with Takayasu arteritis or Behçet's disease have weaker respiratory and limb muscles, lower exercise capacity, or different quality of life and psychological well‑being compared with healthy adults.
-
Butantan live tetravalent dengue vaccine for people with autoimmune rheumatic diseases
This study will test whether a single dose of the Butantan live tetravalent dengue vaccine is safe and produces immune responses in clinically stable people aged 12–59 with autoimmune rheumatic diseases compared with matched healthy volunteers.
-
Imaging in Inflammatory Heart Diseases linked to autoimmune disorders
This study tests how well multimodality imaging (CMR, echocardiography, and PET) detects inflammation in people with suspected inflammatory heart or autoimmune rheumatic diseases.
-
Blocking endothelin to improve blood vessel function in large vessel vasculitis
This study is testing if a medication called Bosentan can improve blood vessel function in people with large vessel vasculitis who have been in remission for at least six months.
-
Comparing precision treatment to conventional treatment for Takayasu's arteritis
This study is testing if a personalized treatment plan for Takayasu's arteritis works better than standard treatment for people with this condition.
-
Nationwide registry for systemic autoimmune and autoinflammatory diseases in Armenia
This study is trying to gather information about systemic autoimmune and autoinflammatory diseases in Armenia to better understand how these conditions progress and how they are treated.
-
Evaluating treatments for severe Takayasu arteritis
This study tests whether tocilizumab or adalimumab is more effective for people with severe Takayasu arteritis to help tailor treatments based on their specific needs.
-
Collection of tissue samples for vasculitis research
This study is collecting tissue samples from patients with vasculitis to see if they can help researchers understand the disease better and find new ways to diagnose and treat it.
Related topics
Quick answers
How many Takayasu Arteritis clinical trials are recruiting right now?
10, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 8 countries. The most sites are in United Kingdom (2 trials), China (2 trials), Turkey (Türkiye) (2 trials), Brazil (1 trial), Armenia (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 3, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.